Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,927,242
+$1,927,242 QoQ
Shares Held
103,006
Ownership
0.047%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#103
of 256 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Derivatives in RLAY
reported options exposure · as of Jun 30, 2026CallValue
$3,087,150
CallShares
165,000
PutValue
$23,323,886
PutShares
1,246,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. RLAY ranks #27 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in RLAY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,087,150 | 165,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $23,323,886 | 1,246,600 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $1,927,242 | 103,006 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $597,000 | 60,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $10,547,000 | 1,060,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $4,230,846 | 500,100 | Call | Sole | 2026-02-17 | |
| 2024-09-30 | $49,560 | 7,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $130,980 | 18,500 | Call | Sole | 2024-11-14 | |
| 2023-03-31 | $419,770 | 25,487 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $149,650 | 5,000 | Shares | Sole | 2022-05-13 | |
| 2022-03-31 | $299,300 | 10,000 | Put | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||